Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution in Children and Young Adults With Hematologic Malignancies

NCT06131801 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.

NCT NCT06131801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06131801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution in Children and Young Adults With Hematologic Malignancies
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Phase
Observational
Overall status
Recruiting
Start date
November 15, 2023
Completion date
December 1, 2027
Enrollment
30 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphocytic leukemia, acute myelogenous leukemia, all, aml, b cell lymphoma, burkitt lymphoma, chronic myelogenous leukemia, cml, cutaneous b-cell lymphoma, diffuse large b cell lymphoma, follicular lymphoma, hematologic malignancy, hodgkin lymphoma, leukemia, lymphoma, myeloproliferative neoplasm, non hodgkin lymphoma, peripheral t cell lymphoma, t-cell lymphoma